Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Theoretical Approaches to Psychological Disorder01:29

Theoretical Approaches to Psychological Disorder

The development of psychological disorders, which are characterized by deviant, maladaptive, and personally distressing behaviors, has been explored through several theoretical approaches.
Biological approach
The biological approach posits that internal, organic factors are the primary causes of such disorders. This perspective emphasizes brain structure and function, genetic predispositions, and neurotransmitter imbalances. For example, schizophrenia has been associated with both genetic...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment and long-term outcome of mental disorders: The grim picture from a quasi-epidemiological investigation in 54,826 subjects from 40 countries.

Psychiatry research·2025
Same author

Electrochemical Method for the Assay of Organic Peroxides Directly in Acetonitrile.

Molecules (Basel, Switzerland)·2025
Same author

Non-binary gender, vulnerable populations and mental health during the COVID-19 pandemic: Data from the COVID-19 MEntal health inTernational for the general population (COMET-G) study.

Journal of affective disorders·2024
Same author

Students' mental health during the pandemic: results of the observational cross-sectional COVID-19 MEntal health inTernational for university Students (COMET-S) study.

Frontiers in psychiatry·2024
Same author

Somatic multicomorbidity and disability in patients with psychiatric disorders in comparison to the general population: a quasi-epidemiological investigation in 54,826 subjects from 40 countries (COMET-G study).

CNS spectrums·2024
Same author

Novel Flurbiprofen Derivatives as Antioxidant and Anti-Inflammatory Agents: Synthesis, In Silico, and In Vitro Biological Evaluation.

Molecules (Basel, Switzerland)·2024

Related Experiment Video

Updated: May 7, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Bipolar disorder - from endophenotypes to treatment.

Luchezar G Hranov1, Petra Marinova, Maria Stoyanova

  • 1Second Psychiatric Clinic of the University Hospital for Active Treatment, in Neurology and Psychiatry "Sveti Naum" 1, Dr. Lyuben Russev Street, 1113 Sofia, Bulgaria, lucho.hranov@gmail.com.

Psychiatria Danubina
|September 20, 2013
PubMed
Summary

Researchers identified specific endophenotypes in bipolar affective disorder (BAD), revealing cognitive deficits and neurological soft signs. These findings aid in early diagnosis and understanding genetic vulnerability for BAD.

More Related Videos

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Related Experiment Videos

Last Updated: May 7, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

Area of Science:

  • Psychiatry
  • Neuroscience
  • Genetics

Background:

  • Bipolar affective disorder (BAD) presents complex challenges in classification, diagnosis, clinical management, and understanding its pathogenic mechanisms.
  • Unresolved issues persist in the comprehensive understanding and treatment of BAD.

Purpose of the Study:

  • To identify discrete endophenotypes in bipolar affective disorder (BAD).

Main Methods:

  • Studied patients with bipolar I, bipolar II, and recurrent depression, alongside healthy controls.
  • Utilized descriptive data, clinician- and self-rated scales for neurological and psychopathological symptoms, neurocognitive assessments, and temperamental/characterological inventories.
  • Evaluated the efficacy, tolerability, and cost-benefit of sodium valproate for acute mania treatment.

Main Results:

  • BAD patients exhibit deficits in memory, selective attention, working memory, and psychomotor speed.
  • Neurological soft signs (sensory, motor) are integral to BAD symptomatology.
  • Hyperthymic temperament is not linked to the bipolar spectrum, but cyclothymia indicates vulnerability. Lower self-transcendence was observed in BAD patients.
  • Early onset, mood lability, and specific diurnal patterns differentiate bipolar from unipolar depression.
  • Intravenous sodium valproate is highly effective and cost-efficient for acute mania.

Conclusions:

  • Discovering BAD endophenotypes can improve early diagnosis and treatment accuracy.
  • Identifying endophenotypes aids in understanding the genetic vulnerability associated with bipolar affective disorder.
  • These findings contribute to better clinical management and a deeper understanding of BAD's underlying mechanisms.